Method for treating interleukin-1 mediated diseases

Details Method for treating interleukin-1 mediated diseases Method for treating interleukin-1 mediated diseases

1994-08-18

2000-12-12

Mertz, Prema

Drug, bio-affecting and body treating compositions

Lymphokine

514 2, 514 8, 514 12, 514885, A61K 3819

Patent

active

061594601

ABSTRACT:
The present invention provides methods for treating interleukin-1 mediated diseases including arthritis, inflammatory bowel disease, sepsis and septic shock, ischemia injury, reperfusion injury, multiple sclerosis and cerebral infarctions such as cerebral palsy. The methods are accomplished by administering to a patient in need thereof a therapeutically effective amount of an interleukin-1 inhibitor.

REFERENCES:
patent: 4935343 (1990-06-01), Allison et al.
patent: 4956381 (1990-09-01), Bollinger et al.
patent: 4968607 (1990-11-01), Dower et al.
patent: 5041554 (1991-08-01), Parker et al.
patent: 5075222 (1991-12-01), Hannum et al.
patent: 5359032 (1994-10-01), Dayer et al.
Bowie et al. Science 1990, vol. 247, pp. 1306-1310.
Tan et al. Australian & New Zealand Rhematism Associations. p. 113 (1986).
Biotechnology Bulletin, Jun. 31, 1994, vol. 13, No. 6, p. 2.
Bulletin International d'Informations (Droit et Pharmacie) Sep. 21, 1994, Aug. 9, p. 89.
Seckinger et al. (1987) J. of Immunol. vol. 139. pp. 1546-1549.
Seckinger et al. (1987) Ann. Inst. Pasteur Immunol. vol. 138. pp. 486-488.
Okusawa et al. (1988) J. Clin. Invest. vol. 81. pp. 1162-1172.
Sullivan et al. (1988) Infection & Immunity vol. 56 pp. 1722-1729.
Cominelli et al. (1989) Biotherapy vol. 1, pp. 369-375.
Dinarello et al. (1988) Digestive Diseases & Sciences vol. 33, pp. 255-355.
Billingham (1985) Br. J. of Rhematology vol. 24, pp. 25-28.
Pujol et al. (1987) Life Sciences vol. 41 pp. 1187-1198.
Relton & Rothwell , Brain Res. Bull. 29:243-246 (1992).
Rothwell & Relton, Neurosci. Biobehav. Rev. 17:217-227 (1993).
Conti et al, Int. J. Immunopharmae 14(6):987-993 (1992).
Seckinger et al, J. Immunol. 139:1546-1549 (1987).
Pujol & Loyau, Life Sciences 41:1187-1198 (1987).
Eisenberg et al, Nature 343:341-346 (1990).
Tan et al, Australian & New Zealand Rheumatism Assoc. 1987 17(1):113 (Abstract).
Seckinger & Dayer, 18th Forum in Immunol. 486-488 (1987).
Billingham, Br. J. Rheumatology 24 (Suppl. 1):25-28 (1985).
Stimpson et al. J. Immunol. 140:2964-2969 (1988).
Hannum et al, Nature 343:336-340 (1990).
Arend et al, J. Immunol. 143(6): 1851-1858 (1989).
Cominelli et al, Biotherapy 1(4):369-375 (1989).
Cominelli et al, Gastroenterology 97(6): 1400-1405 (1989).
Dinarello, Digestive Diseases & Sciences 33(Suppl 3): 255-355 (1988).
Okusawa et al, J. Clin. Invest. 81(4): 1162-1172 (1988).
Sullivan et al, Infect. Immunol. 56(7): 1722-1729 (1988).
Dinarello, Blood 77(8): 1627-1652 (1991).
Cominelli et al, J. Clin. Invest. 86:972-980 (1990).
Ohlsson et al. Nature 348:550-552 (1990).
Ulich et al, Am J. Pathology 138(3):521-524 (1991).
Thomas et al, Agents & Action 34:187-190 (1991).
Seckinger et al, J. Immunol. 145:4181-4184 (1990).
Wakabayashi et al, FASEB J. 5(3):338-343 (1991).
Lotz et al, Arthritis Rheum, 29:S38 #162 (Abstract).
Poli et al, Proc. Natl. Acad. Sci. USA 91:108-112(1994).
Piguet et al, Cytokine 5(1): 57-61 (1993).
Wooley et al, Arthritis & Rheumatism 36(9): 1305-1314 (1993).
Rolfe et al, Am. Rev. Respir. Dis. 148:1378-1384 (1993).
Moldawer, Blood Purif. 11:128-133 (1993).
Pillay et al, Pflugers Arch. 424:549-551 (1993).
Ferrara, Keystone Symposium on Cellular Immunity & the Immuno-therapy of Cancer, Mar. 17-24, 1993, p. 96 (Abstract No. NZ 019).
Catalano, Keystone Symposium on Cytokines and Cytokine Receptors, Jan. 31-Feb. 7, 1993, p. 55 (Abstract No. E 016).
Cannon et al., "Circulating Interleukin-1 and Tumor Necrosis Factor in Septic Shock and Experimental Endotoxin Fever", Journal of Infectious Diseases 161:79-84 (1990).
Eichacker et al., "The Effects of Human Recombinant Interleukin-1 (IL-1) On Canine Alveolar Neutrophil (N) Number And Lung Function", Critical Care Medicine, Apr., 1989 p. S58.
Girardin et al, "Tumor Necrosis Factor and Interlukin-1 In The Serum of Children With Severe Infectious Purpura", New England Journal of Medicine 319(7):397-400 (1988).
Hilton et al., "A Report on the International Conference on Inflammation Held in Rome, Oct. 6-11, 1991", DN & P5(1):59-62 (1992).
Rosenstreich et al., "A Human Urine-Derived Interleukin1 Inhibitor: Homology with Deoxyribonuclease 1", J. Exp. Med. 168:1767-1779 (1988).
Takahashi K., "Basal and Clinical Investifation of Urine IL-1 Inhibitor", Medical Journal of Hiroshima University35(4):813-842 (1987).
Ziegler et al., "Treatment of Gram-Negative Bacteremia and Shock With Human Antiserum to a Mutant Escherichia coli", New England Journal of Medicine 307:1225-1230 (1982).

Affiliated with

Also associated with

Rating

Method for treating interleukin-1 mediated diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for treating interleukin-1 mediated diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating interleukin-1 mediated diseases will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-213456